International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

New Corporate Member

new corporate member anaptysbio

The International Psoriasis Council is pleased to welcome AnaptysBio as a 2022 Bronze Level Corporate Member. AnaptysBio, based in San Diego, California, is a clinical-stage biotechnology company developing first-in-class immunology therapeutic product candidates for patients. They are focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. “We are extremely pleased to welcome AnaptysBio to the IPC family and look forward to working with them to improve the care of people with psoriasis worldwide through education, research, and advocacy,” said IPC CEO Christy Langan.

Learn more about AnaptysBio.


Recent Posts

Expert Insights IPC and IFPA CEO

IFPA and IPC Partnership One Year Later — Joining the Clinical and Patient Perspectives

New Councilor Headshots

Meet Our Newest Councilors

IPC and IFPA strongly advocate that early diagnosis is crucial and must be available for all individuals regardless of race, ethnicity, physical ability, culture, nationality, or geographic location blog graphic

IPC and IFPA Joint Statement on Diversity and Inclusion

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.